Antihemophilic factor B (Armour)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAntihemophilic factor B (Armour)
Drug Alias NameAHF-BMonoFIXMononine
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1993/05/01
Country/TerritoryFrance
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesArmour PharmaCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeB02BD04
Related LinksN/A